Skip to main content
Erschienen in: Herz 3/2021

27.05.2020 | Original articles

Serum osteoprotegerin level is independently related to subclinical left atrial mechanical function in patients with hypertension and diabetes

verfasst von: Ezgi Kalaycıoğlu, MD, Mustafa Çetin, MD, Göksel Çinier, MD, Tuncay Kırış, MD, Tayyar Gökdeniz, MD, Ali Gökhan Özyıldız, MD, İsmet Durmuş, MD

Erschienen in: Herz | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Previous studies showed that subclinical abnormal left atrial (LA) function could be diagnosed with LA speckle tracking evaluation long before chamber enlargement. Osteoprotegerin (OPG) is a member of the tumor necrosis factor (TNF) receptor superfamily and was recently found to be an indicator for adverse cardiovascular outcomes and a risk factor for new onset atrial fibrillation. The authors hypothesized that OPG values could predict LA mechanical dysfunction and LA remodeling assessed by two-dimensional speckle tracking echocardiography (2D-STE) in patients with hypertension (HT) and diabetes mellitus (DM).

Methods

A single center study was conducted including consecutive patients presenting to the authors’ outpatient clinic. Enrolled patients needed to have been treated for HT and DM for at least 1 year.

Results

The study included 80 patients (mean age, 57.5 ± 8.3 years). Patients in the impaired LA strain group were older (p = 0.035), had lower low density lipoprotein (LDL) cholesterol (mg/dl) (p = 0.021), and higher OPG (pmol/l) (p = 0.004) values than patients in the normal LA strain group. Univariate logistic regression analysis demonstrated that age (p = 0.039), LDL cholesterol (mg/dl) (p = 0.025), and OPG (pmol/l) (p = 0.008) values were associated with impaired LA strain. Backward multivariate logistic regression analysis showed that LDL cholesterol (mg/dl) (OR: 0.982, CI 95% 0.964–0.999, p = 0.049) and OPG (pmol/l) (OR: 1.438, CI 95% 1.043–1.983, p = 0.027) were independently associated with impaired LA strain.

Conclusion

In hypertensive and diabetic patients, higher OPG values were associated with impaired LA function assessed by 2D-STE. In this high-risk patient group, serum OPG can be used as a risk predictor for LA mechanical dysfunction.
Literatur
1.
Zurück zum Zitat Verdecchia P, Angeli F, Reboldi G (2018) Hypertension and atrial fibrillation: doubts and certainties from basic and clinical studies. Circ Res 122(2):352–368CrossRef Verdecchia P, Angeli F, Reboldi G (2018) Hypertension and atrial fibrillation: doubts and certainties from basic and clinical studies. Circ Res 122(2):352–368CrossRef
2.
Zurück zum Zitat Wang A et al (2019) Atrial fibrillation and diabetes mellitus: JACC review topic of the week. J Am Coll Cardiol 74(8):1107–1115CrossRef Wang A et al (2019) Atrial fibrillation and diabetes mellitus: JACC review topic of the week. J Am Coll Cardiol 74(8):1107–1115CrossRef
3.
Zurück zum Zitat Mondillo S et al (2011) Early detection of left atrial strain abnormalities by speckle tracking in hypertensive and diabetic patients with normal left atrial size. J Am Soc Echocardiogr 24(8):898–908CrossRef Mondillo S et al (2011) Early detection of left atrial strain abnormalities by speckle tracking in hypertensive and diabetic patients with normal left atrial size. J Am Soc Echocardiogr 24(8):898–908CrossRef
4.
Zurück zum Zitat Vianna-Pinton R et al (2009) Two-dimensional speckle-tracking echocardiography of the left atrium: feasibility and regional contraction and relaxation differences in normal subjects. J Am Soc Echocardiogr 22(3):299–305CrossRef Vianna-Pinton R et al (2009) Two-dimensional speckle-tracking echocardiography of the left atrium: feasibility and regional contraction and relaxation differences in normal subjects. J Am Soc Echocardiogr 22(3):299–305CrossRef
5.
Zurück zum Zitat Simonet WS et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89(2):309–319CrossRef Simonet WS et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89(2):309–319CrossRef
6.
Zurück zum Zitat Ueland T et al (2005) Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure. Circulation 111(19):2461–2468CrossRef Ueland T et al (2005) Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure. Circulation 111(19):2461–2468CrossRef
7.
Zurück zum Zitat Reinhard H (2010) Osteoprotegerin and mortality in type 2 diabetic patients. Diabetes Care 33(12):2561–2566CrossRef Reinhard H (2010) Osteoprotegerin and mortality in type 2 diabetic patients. Diabetes Care 33(12):2561–2566CrossRef
8.
Zurück zum Zitat Blazquez-Medela AM et al (2012) Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes. Eur J Clin Invest 42(5):548–556CrossRef Blazquez-Medela AM et al (2012) Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes. Eur J Clin Invest 42(5):548–556CrossRef
9.
Zurück zum Zitat Liu W, Zhang X (2015) Receptor activator of nuclear factor-kappaB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review). Mol Med Rep 11(5):3212–3218CrossRef Liu W, Zhang X (2015) Receptor activator of nuclear factor-kappaB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review). Mol Med Rep 11(5):3212–3218CrossRef
10.
Zurück zum Zitat Imai E et al (2007) Modification of the modification of diet in renal disease (MDRD) study equation for Japan. Am J Kidney Dis 50(6):927–937CrossRef Imai E et al (2007) Modification of the modification of diet in renal disease (MDRD) study equation for Japan. Am J Kidney Dis 50(6):927–937CrossRef
11.
Zurück zum Zitat Nagueh SF et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29(4):277–314CrossRef Nagueh SF et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29(4):277–314CrossRef
12.
Zurück zum Zitat Lang RM et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1–39e14CrossRef Lang RM et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1–39e14CrossRef
13.
Zurück zum Zitat Badano LP et al (2018) Industry representatives; reviewers: this document was reviewed by members of the 2016–2018 EACVI scientific documents committee. Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/industrytask force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging 19(6):591–560CrossRef Badano LP et al (2018) Industry representatives; reviewers: this document was reviewed by members of the 2016–2018 EACVI scientific documents committee. Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/industrytask force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging 19(6):591–560CrossRef
14.
Zurück zum Zitat Pathan F et al (2017) Normal ranges of left atrial strain by speckle-tracking echocardiography: a systematic review and meta-analysis. J Am Soc Echocardiogr 30(1):59–70CrossRef Pathan F et al (2017) Normal ranges of left atrial strain by speckle-tracking echocardiography: a systematic review and meta-analysis. J Am Soc Echocardiogr 30(1):59–70CrossRef
15.
Zurück zum Zitat Thomas L, Abhayaratna WP (2017) Left atrial reverse remodeling: mechanisms, evaluation, and clinical significance. JACC Cardiovasc Imaging 10(1):65–77CrossRef Thomas L, Abhayaratna WP (2017) Left atrial reverse remodeling: mechanisms, evaluation, and clinical significance. JACC Cardiovasc Imaging 10(1):65–77CrossRef
16.
Zurück zum Zitat Nattel S (2017) Molecular and cellular mechanisms of atrial fibrosis in atrial fibrillation. JACC Clin Electrophysiol 3(5):425–435CrossRef Nattel S (2017) Molecular and cellular mechanisms of atrial fibrosis in atrial fibrillation. JACC Clin Electrophysiol 3(5):425–435CrossRef
17.
Zurück zum Zitat Koyama S et al (2014) Osteoprotegerin is secreted into the coronary circulation: a possible association with the renin-angiotensin system and cardiac hypertrophy. Horm Metab Res 46(8):581–586CrossRef Koyama S et al (2014) Osteoprotegerin is secreted into the coronary circulation: a possible association with the renin-angiotensin system and cardiac hypertrophy. Horm Metab Res 46(8):581–586CrossRef
18.
Zurück zum Zitat Cao H et al (2014) Serum sRANKL/OPG predict recurrence after radiofrequency catheter ablation of lone atrial fibrillation. Int J Cardiol 170(3):298–302CrossRef Cao H et al (2014) Serum sRANKL/OPG predict recurrence after radiofrequency catheter ablation of lone atrial fibrillation. Int J Cardiol 170(3):298–302CrossRef
19.
Zurück zum Zitat Xi L et al (2013) OPG/RANK/RANKL axis in stabilization of spontaneously restored sinus rhythm in permanent atrial fibrillation patients after mitral valve surgery. Cardiology 124(1):18–24CrossRef Xi L et al (2013) OPG/RANK/RANKL axis in stabilization of spontaneously restored sinus rhythm in permanent atrial fibrillation patients after mitral valve surgery. Cardiology 124(1):18–24CrossRef
20.
Zurück zum Zitat Schnabel RB et al (2009) Relation of multiple inflammatory biomarkers to incident atrial fibrillation. Am J Cardiol 104(1):92–96CrossRef Schnabel RB et al (2009) Relation of multiple inflammatory biomarkers to incident atrial fibrillation. Am J Cardiol 104(1):92–96CrossRef
21.
Zurück zum Zitat Cao Y et al (2019) Plasma osteoprotegerin correlates with stroke severity and the occurrence of microembolic signals in patients with acute ischemic stroke. Dis Markers 2019:3090364PubMedPubMedCentral Cao Y et al (2019) Plasma osteoprotegerin correlates with stroke severity and the occurrence of microembolic signals in patients with acute ischemic stroke. Dis Markers 2019:3090364PubMedPubMedCentral
22.
Zurück zum Zitat Songia P et al (2016) Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition. J Mol Cell Cardiol 98:48–57CrossRef Songia P et al (2016) Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition. J Mol Cell Cardiol 98:48–57CrossRef
23.
Zurück zum Zitat Kawakami H et al (2019) Left atrial mechanical dispersion assessed by strain echocardiography as an independent predictor of new-onset atrial fibrillation: a case-control study. J Am Soc Echocardiogr 32(10):1268–1276e3CrossRef Kawakami H et al (2019) Left atrial mechanical dispersion assessed by strain echocardiography as an independent predictor of new-onset atrial fibrillation: a case-control study. J Am Soc Echocardiogr 32(10):1268–1276e3CrossRef
24.
Zurück zum Zitat Rosca M et al (2011) Left atrial function: pathophysiology, echocardiographic assessment, and clinical applications. Heart 97(23):1982–1989CrossRef Rosca M et al (2011) Left atrial function: pathophysiology, echocardiographic assessment, and clinical applications. Heart 97(23):1982–1989CrossRef
25.
Zurück zum Zitat Çetin M et al (2020) Endothelial dysfunction, subclinical atherosclerosis andLDL cholesterol are the independent predictors of left atrial functions inhypertension. Int J Cardiovasc Imaging 36(1):69–77CrossRef Çetin M et al (2020) Endothelial dysfunction, subclinical atherosclerosis andLDL cholesterol are the independent predictors of left atrial functions inhypertension. Int J Cardiovasc Imaging 36(1):69–77CrossRef
26.
Zurück zum Zitat Li ZZ et al (2018) Association between blood lipid profiles and atrial fibrillation: a case–control study. Med Sci Monit 24:3903–3908CrossRef Li ZZ et al (2018) Association between blood lipid profiles and atrial fibrillation: a case–control study. Med Sci Monit 24:3903–3908CrossRef
Metadaten
Titel
Serum osteoprotegerin level is independently related to subclinical left atrial mechanical function in patients with hypertension and diabetes
verfasst von
Ezgi Kalaycıoğlu, MD
Mustafa Çetin, MD
Göksel Çinier, MD
Tuncay Kırış, MD
Tayyar Gökdeniz, MD
Ali Gökhan Özyıldız, MD
İsmet Durmuş, MD
Publikationsdatum
27.05.2020
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 3/2021
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-020-04939-7

Weitere Artikel der Ausgabe 3/2021

Herz 3/2021 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.